Cambridge Nutritional Science (CNSL)

Sector:

Health Care

Index:

FTSE AIM All-Share

3.60p
   
  • Change Today:
    -0.050p
  • 52 Week High: 4.35p
  • 52 Week Low: 1.73p
  • Currency: UK Pounds
  • Shares Issued: 237.95m
  • Volume: 455,064
  • Market Cap: £8.57m

Omega Diagnostics files for CE-mark on Covid-19 self-test

By Josh White

Date: Monday 06 Sep 2021

LONDON (ShareCast) - (Sharecast News) - Medical diagnostics company Omega announced on Monday that all of the supporting data and documentation relating to its submission for CE-marking for self-test use of its 'Visitect' Covid-19 antigen test had been filed with its European notified body.
The AIM-traded firm said the submission process had been running in parallel with the useability study conducted by Ulster University since mid-July, with the conclusion of the Ulster study being the final step in the process.

It said the test was already CE-marked for professional-use, and once approved, would allow it to be sold in Europe for home-use as well.

As the global market for antigen testing develops, the company said it believed self-test approval would be a "key" requirement, as had already been seen in the UK.

The submission was already under review by the notified body, the board said.

"As a result of a lot of hard work by our team and Ulster University, we are very pleased to have submitted all of the information required for self-test use approval for our Visitect Covid-19 antigen test," said chief executive officer Colin King.

"Once approval is granted, we anticipate strong demand for a UK developed and manufactured product.

"Furthermore, we believe we have a high-quality, high-performance product with significant global appeal, including the United States market, due to that market's size and high barriers to entry."

At 1542 BST, shares in Omega Diagnostics Group were up 2.64% at 54.4p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CNSL Market Data

Currency UK Pounds
Share Price 3.60p
Change Today -0.050p
% Change -1.37 %
52 Week High 4.35p
52 Week Low 1.73p
Volume 455,064
Shares Issued 237.95m
Market Cap £8.57m

CNSL Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
73.19% above the market average73.19% above the market average73.19% above the market average73.19% above the market average73.19% above the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Income Not Available
Growth Not Available

CNSL Dividends

No dividends found

Trades for 15-Jul-2024

Time Volume / Share Price
13:05 50,052 @ 3.51p
12:16 18,000 @ 3.51p
09:54 200,000 @ 3.57p
10:23 15,532 @ 3.51p
09:54 100,000 @ 3.56p

Top of Page